BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36411653)

  • 21. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
    Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
    Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
    Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
    Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein disulphide isomerase (PDI) is protective against amyotrophic lateral sclerosis (ALS)-related mutant Fused in Sarcoma (FUS) in in vitro models.
    Parakh S; Perri ER; Vidal M; Sultana J; Shadfar S; Mehta P; Konopka A; Thomas CJ; Spencer DM; Atkin JD
    Sci Rep; 2021 Sep; 11(1):17557. PubMed ID: 34475430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic Homeostasis Disruption in a Novel Frontotemporal Dementia Mouse Model Expressing Cytoplasmic Fused in Sarcoma.
    Shiihashi G; Ito D; Arai I; Kobayashi Y; Hayashi K; Otsuka S; Nakajima K; Yuzaki M; Itohara S; Suzuki N
    EBioMedicine; 2017 Oct; 24():102-115. PubMed ID: 28928015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Regulatory Circuitry Between Gria2, miR-409, and miR-495 Is Affected by ALS FUS Mutation in ESC-Derived Motor Neurons.
    Capauto D; Colantoni A; Lu L; Santini T; Peruzzi G; Biscarini S; Morlando M; Shneider NA; Caffarelli E; Laneve P; Bozzoni I
    Mol Neurobiol; 2018 Oct; 55(10):7635-7651. PubMed ID: 29430619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis.
    Farg MA; Soo KY; Warraich ST; Sundaramoorthy V; Blair IP; Atkin JD
    Hum Mol Genet; 2013 Feb; 22(4):717-28. PubMed ID: 23172909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular regression precedes motor neuron loss in the FUS (1-359) ALS mouse model.
    Crivello M; Hogg MC; Jirström E; Halang L; Woods I; Rayner M; Coughlan KS; Lewandowski SA; Prehn JHM
    Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31383794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.
    Aizawa H; Hideyama T; Yamashita T; Kimura T; Suzuki N; Aoki M; Kwak S
    J Clin Neurosci; 2016 Oct; 32():128-9. PubMed ID: 27343041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice.
    Ahn SW; Kim JE; Park KS; Choi WJ; Hong YH; Kim SM; Kim SH; Lee KW; Sung JJ
    J Neurol Sci; 2012 Sep; 320(1-2):1-5. PubMed ID: 22698482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].
    Aoki M; Warita H; Suzuki N; Itoyama Y
    Rinsho Shinkeigaku; 2009 Nov; 49(11):814-7. PubMed ID: 20030218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.
    Groen EJ; Fumoto K; Blokhuis AM; Engelen-Lee J; Zhou Y; van den Heuvel DM; Koppers M; van Diggelen F; van Heest J; Demmers JA; Kirby J; Shaw PJ; Aronica E; Spliet WG; Veldink JH; van den Berg LH; Pasterkamp RJ
    Hum Mol Genet; 2013 Sep; 22(18):3690-704. PubMed ID: 23681068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
    Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
    Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice.
    Chaprov K; Rezvykh A; Funikov S; Ivanova TA; Lysikova EA; Deykin AV; Kukharsky MS; Yu Aksinenko A; Bachurin SO; Ninkina N; Buchman VL
    CNS Neurosci Ther; 2021 Jul; 27(7):765-775. PubMed ID: 33754495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
    Strong MJ; Volkening K
    FEBS J; 2011 Oct; 278(19):3569-77. PubMed ID: 21810174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abundant FUS-immunoreactive pathology in the skin of sporadic amyotrophic lateral sclerosis.
    Oketa Y; Higashida K; Fukasawa H; Tsukie T; Ono S
    Acta Neurol Scand; 2013 Oct; 128(4):257-64. PubMed ID: 23448665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.
    Lagier-Tourenne C; Polymenidou M; Hutt KR; Vu AQ; Baughn M; Huelga SC; Clutario KM; Ling SC; Liang TY; Mazur C; Wancewicz E; Kim AS; Watt A; Freier S; Hicks GG; Donohue JP; Shiue L; Bennett CF; Ravits J; Cleveland DW; Yeo GW
    Nat Neurosci; 2012 Nov; 15(11):1488-97. PubMed ID: 23023293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay.
    Kamelgarn M; Chen J; Kuang L; Jin H; Kasarskis EJ; Zhu H
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11904-E11913. PubMed ID: 30455313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.